Informazione:
Errore:
ID
29939
Descrizione
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00698646
collegamento
https://clinicaltrials.gov/show/NCT00698646
Keywords
versioni (1)
- 28/04/18 28/04/18 -
Titolare del copyright
See clinicaltrials.gov
Caricato su
28 aprile 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Hypertension NCT00698646
Eligibility Hypertension NCT00698646
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00698646
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Age
Item
age 70 years or older.
boolean
C0001779 (UMLS CUI [1])
Hypertensive disease
Item
patients with hypertension prior to being randomized into study.
boolean
C0020538 (UMLS CUI [1])
Sitting systolic blood pressure mean
Item
patients must have an office cuff mssbp ≥ 140 and ≤ 200 mmhg systolic.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C0444504 (UMLS CUI [1,2])
Protocol Compliance
Item
have the ability to communicate and comply with all study requirements.
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
provide written informed consent to participate in the study prior to any screening or study procedures.
boolean
C0021430 (UMLS CUI [1])
Investigational New Drugs
Item
use of other investigational drugs within 30 days of enrollment.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Similar
Item
history of hypersensitivity to any of the study drugs or to drugs of similar chemical classes.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
Blood pressure determination | Sitting diastolic blood pressure mean
Item
office blood pressure measured by office machine cuff with a mean of (3) msdbp ≥ 120 mmhg at anytime during the screening / washout period.
boolean
C0005824 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Antihypertensive Agents Quantity | Sitting systolic blood pressure mean
Item
patients taking 3 or more antihypertensive drugs and mssbp ≥ 160 mmhg at the time of visit 1.
boolean
C0003364 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])